within Pharmacolibrary.Drugs.ATC.L;

model L01CE03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.11 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 145 / 1000000,
    adminCount     = 1,
    Vd             = 0.006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Etirinotecan pegol is a long-acting topoisomerase I inhibitor composed of irinotecan attached to a polyethylene glycol (PEG) polymer to provide sustained release of the active metabolite SN-38. It was developed for the treatment of advanced solid tumors, including metastatic breast cancer. It has undergone clinical trials but is not currently approved by the FDA or EMA for medical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult cancer patients (primarily women) treated intravenously with etirinotecan pegol in phase 2/3 trials.</p><h4>References</h4><ol><li><p>Hoch, U, et al., &amp; Eldon, MA (2014). Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models. <i>Cancer chemotherapy and pharmacology</i> 74(6) 1125–1137. DOI:<a href=&quot;https://doi.org/10.1007/s00280-014-2577-7&quot;>10.1007/s00280-014-2577-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25228368/&quot;>https://pubmed.ncbi.nlm.nih.gov/25228368</a></p></li><li><p>Sy, SK, et al., &amp; Eldon, MA (2017). Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration. <i>Cancer chemotherapy and pharmacology</i> 79(1) 57–67. DOI:<a href=&quot;https://doi.org/10.1007/s00280-016-3192-6&quot;>10.1007/s00280-016-3192-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27904955/&quot;>https://pubmed.ncbi.nlm.nih.gov/27904955</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01CE03;
